Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers
A Randomized, Controlled Trial of the Procellera™ Wound Dressing Used With Negative Pressure Wound Therapy (NPWT) in the Healing of Diabetic and Pressure Ulcers of the Foot
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to determine whether a bioelectric wound dressing, used in conjunction with Negative Pressure Wound Therapy (NPWT), is effective in the treatment of diabetic and pressure ulcers of the foot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Aug 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 24, 2009
CompletedFirst Posted
Study publicly available on registry
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFebruary 22, 2012
February 1, 2012
2 years
November 24, 2009
February 20, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound healing over time
3 months after enrollment
Secondary Outcomes (1)
Pain reduction
3 months
Study Arms (2)
V.A.C.® Therapy
ACTIVE COMPARATORVacuum Assisted Closure device that utilizes controlled negative pressure
Procellera™ Wound Dressing with V.A.C.® Therapy
EXPERIMENTALProcellera wound dressing used as a primary contact layer on the wound bed, used in conjunction with NPWT
Interventions
Dressing indicated for partial and full-thickness wounds. Weekly dressing changes, more frequently if needed. Used as a primary contact layer in conjunction with NPWT.
Vacuum Assisted Closure device that uses controlled negative pressure, with dressing changes 1x/week.
Eligibility Criteria
You may qualify if:
- Wound size greater than 1x1 cm
- Wounds must be ≥5 cm away from all other wounds
- Wound size must not be diminished in size greater than 10% between enrollment in study and the prescreening
- Participant must be candidate for negative pressure wound therapy
- Participant agrees to participate in follow-up evaluations
- Participant must be able to read and understand informed consent, and sign the informed consent
You may not qualify if:
- Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study
- Participant is to receive another topical agent (antimicrobials, enzymes, etc.) other than the study dressing (granufoam)
- Participant is to receive Silver granufoam for their wound
- Participant with sensitivity or adverse reactions to silver or zinc
- Pregnancy or nursing an infant or child
- Immunosuppression
- Active or systemic infection
- Participant undergoing active cancer chemotherapy
- Chronic steroid use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wyckoff Heights Medical Center
Brooklyn, New York, 11237, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald M Guberman, DPM
Wyckoff Heights Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 24, 2009
First Posted
December 1, 2009
Study Start
August 1, 2009
Primary Completion
August 1, 2011
Study Completion
November 1, 2011
Last Updated
February 22, 2012
Record last verified: 2012-02